Search Results
Search for other papers by Bettina Geidl-Flueck in
Google Scholar
PubMed
Search for other papers by Philipp A Gerber in
Google Scholar
PubMed
Introduction Metabolic health is at risk in societies with an excess supply of energy-dense palatable food and drinks and an everyday life with low physical activity. There is a global epidemic of metabolic syndrome ( Saklayen 2018 ), which
Babu Banarasi Das University, BBD City, Lucknow, India
Search for other papers by Alpana Mathur in
Google Scholar
PubMed
Academy of Scientific and Innovative Research, CSIR-IITR, Lucknow, India
Search for other papers by Vivek Kumar Pandey in
Google Scholar
PubMed
Babu Banarasi Das University, BBD City, Lucknow, India
Academy of Scientific and Innovative Research, CSIR-IITR, Lucknow, India
Search for other papers by Poonam Kakkar in
Google Scholar
PubMed
physical exercise and its effect on the hepatic glucose production in an insulin resistance state . Diabetology and Metabolic Syndrome 7 67 . ( doi:10.1186/s13098-015-0064-x ) Mendoza MC Blenis J 2007 PHLPPing it off: phosphatases get in
Search for other papers by Antonio Gonzalez-Bulnes in
Google Scholar
PubMed
Search for other papers by Susana Astiz in
Google Scholar
PubMed
Search for other papers by Cristina Ovilo in
Google Scholar
PubMed
Search for other papers by Clemente J Lopez-Bote in
Google Scholar
PubMed
Search for other papers by Raul Sanchez-Sanchez in
Google Scholar
PubMed
Search for other papers by Maria L Perez-Solana in
Google Scholar
PubMed
Search for other papers by Laura Torres-Rovira in
Google Scholar
PubMed
Search for other papers by Miriam Ayuso in
Google Scholar
PubMed
Search for other papers by Jorge Gonzalez in
Google Scholar
PubMed
undernutrition or overnutrition induces higher body corpulence and adiposity, development of metabolic syndrome and the prodrome of type-2 diabetes in the first generation of descendants ( Barbero et al . 2013 ). The objective of this study was to determine the
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Susan Kralisch in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Johannes Klein in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Ulrike Lossner in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Matthias Bluher in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Michael Stumvoll in
Google Scholar
PubMed
University of Lübeck, Department of Internal Medicine I, 23538 Lübeck, Germany
Search for other papers by Mathias Fasshauer in
Google Scholar
PubMed
symptoms of the metabolic syndrome including insulin resistance and obesity ( Masuzaki et al. 2001 ). Furthermore, studies in humans confirm that local overexpression of 11β-HSD-1 in adipocytes might contribute to insulin resistance found in obesity
Search for other papers by Ivana Vaněčková in
Google Scholar
PubMed
Search for other papers by Lenka Maletínská in
Google Scholar
PubMed
Search for other papers by Michal Behuliak in
Google Scholar
PubMed
Search for other papers by Veronika Nagelová in
Google Scholar
PubMed
Search for other papers by Josef Zicha in
Google Scholar
PubMed
Search for other papers by Jaroslav Kuneš in
Google Scholar
PubMed
epigenetics to obesity, hypertension, and/or metabolic syndrome is less clear ( Egger et al . 2004 , Gallou-Kabani & Junien 2005 ). We can speculate that obesity-related hypertension develops as a consequence of ‘errors’ in well-coordinated regulatory
Search for other papers by Keisuke Ishizawa in
Google Scholar
PubMed
Search for other papers by Narantungalag Dorjsuren in
Google Scholar
PubMed
Search for other papers by Yuki Izawa-Ishizawa in
Google Scholar
PubMed
Search for other papers by Rika Sugimoto in
Google Scholar
PubMed
Search for other papers by Yasumasa Ikeda in
Google Scholar
PubMed
Search for other papers by Yoshitaka Kihira in
Google Scholar
PubMed
Search for other papers by Kazuyoshi Kawazoe in
Google Scholar
PubMed
Search for other papers by Shuhei Tomita in
Google Scholar
PubMed
Search for other papers by Koichiro Tsuchiya in
Google Scholar
PubMed
Search for other papers by Kazuo Minakuchi in
Google Scholar
PubMed
Search for other papers by Toshiaki Tamaki in
Google Scholar
PubMed
Introduction Metabolic syndrome (MS) is known to be associated with obesity, type 2 diabetes mellitus, and hypertension, and the coexistence of these diseases leads to cardiovascular disease (CVD; Sowers et al . 2001 , Lorenzo et al . 2003
Search for other papers by Laurie Rouger in
Google Scholar
PubMed
Search for other papers by G Raphaël Denis in
Google Scholar
PubMed
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, WELBIO, Université Paris Diderot, Euroscreen SA, Université Libre de Bruxelles, Campus Erasme, Route de Lennik 808, B-1070 Brussels, Belgium
Search for other papers by Souphalone Luangsay in
Google Scholar
PubMed
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, WELBIO, Université Paris Diderot, Euroscreen SA, Université Libre de Bruxelles, Campus Erasme, Route de Lennik 808, B-1070 Brussels, Belgium
Search for other papers by Marc Parmentier in
Google Scholar
PubMed
Introduction Obesity and associated disorders, such as type 2 diabetes, metabolic syndrome, and cardiovascular diseases, constitute a rapidly growing health problem in Western countries. According to the World Health Organization, worldwide obesity
Search for other papers by Laura D Ratner in
Google Scholar
PubMed
Hospital General de Agudos J. M. Ramos Mejía, Buenos Aires, Argentina
Search for other papers by Guillermina Stevens in
Google Scholar
PubMed
Search for other papers by Maria Marta Bonaventura in
Google Scholar
PubMed
Search for other papers by Victoria A Lux-Lantos in
Google Scholar
PubMed
Turku Center for Disease Modeling, University of Turku, Turku, Finland
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Search for other papers by Ricardo S Calandra in
Google Scholar
PubMed
Department of Surgery and Cancer, Imperial College London, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Search for other papers by Susana B Rulli in
Google Scholar
PubMed
Introduction Metabolic syndrome is a growing epidemic worldwide that involves 1 out of 4 adult people, and its prevalence increases with age ( Grundy 2008 ). The consensus statement provided by the International Diabetes Federation (IDF
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA
Search for other papers by Rachel T Scarl in
Google Scholar
PubMed
Search for other papers by C Martin Lawrence in
Google Scholar
PubMed
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA
Search for other papers by Hannah M Gordon in
Google Scholar
PubMed
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA
Search for other papers by Craig S Nunemaker in
Google Scholar
PubMed
, glucose intolerance ( Wellen et al. 2007 ) and hyperglycemia, hallmarks of metabolic syndrome and T2D. Thus, STEAP4 appears to play a protective role against metabolic and proinflammatory stress in adipocytes and adipose tissue. STEAP4 expression
Search for other papers by Gisela Helfer in
Google Scholar
PubMed
Search for other papers by Qing-Feng Wu in
Google Scholar
PubMed
Introduction Adipokines, secreted by adipose tissue, are involved in the pathogenesis of metabolic syndrome ( Lehr et al . 2012 ). Chemerin, encoded by the gene retinoic acid receptor responder 2 ( Rarres2 ), also known as tazarotene